Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Improve Detection of ‘Winter Bugs’ with DiaSorin Molecular Technology

Published: Thursday, October 10, 2013
Last Updated: Thursday, October 10, 2013
Bookmark and Share
DiaSorin BUGS’n BEADS™ nucleic acid extraction kits for sensitive and accurate molecular identification of norovirus and Mycoplasma pneumonia.

DiaSorin LIAISON® Ixt / Arrow BUGS’n BEADS™ extraction kits provide high yield, high purity nucleic acid preparations for sensitive and accurate molecular identification of norovirus and Mycoplasma pneumonia.

As winter approaches, clinical laboratories are preparing for an increase in test requests for certain seasonal pathogens, such as norovirus and Mycoplasma pneumonia.

The DiaSorin BUGS’n BEADS™ nucleic acid extraction kits, for use with the automated DiaSorin LIAISON® Ixt / Arrow™ instruments, provide a highly purified nucleic acid preparation from patient samples for sensitive and accurate molecular confirmation of these microorganisms.

Outbreaks of norovirus, also known as winter vomiting disease, can spread quickly in certain semi-closed environments and frequently causes ward closures in hospitals during the winter months. Human noroviruses cannot be grown in cell culture and so diagnostic methods focus on the detection of viral RNA or antigen.

Mycoplasma pneumonia is a common cause of atypical pneumonia. Since other, less common etiological agents exist, which require a different course of treatment, identification of bacterial DNA in clinical samples has become increasingly important in establishing the cause of atypical pneumonia so that the optimal directed therapy can be provided for patients.

The sensitivity and accuracy of nucleic acid detection and amplification techniques can be reduced by interferences caused by the complexity of the sample matrix. The unique magnetic bead technology harnessed by the DiaSorin extraction kits overcomes this problem by concentrating the target microorganisms from a variety of sample matrices, including urine, sputum, culture and swabs, and then providing a highly purified nucleic acid extraction for downstream molecular analysis. No enzymatic pre-treatment or prior heat treatment is required.

The DiaSorin extraction kit solutions automate the purification and nucleic acid extraction process, reducing technician hands-on time and increasing sample throughput, making it ideal for the increasing workloads experienced during the winter months. The BUGS’n BEADS™ cartridges are simply loaded onto the LIAISON® Ixt / Arrow™ instrument for up to 12 patient samples and, in less than 45 minutes, a high yield, high purity nucleic acid preparation is then ready for use in a number of downstream applications.

DiaSorin BUGS’n BEADS™ can be used for the extraction of nucleic acid from a variety of pathogens, including Mycobacterium tuberculosis, enterovirus, MRSA, norovirus, Escherichia coli, Legionella, Mycoplasma pneumonia, Chlamydia pneumonia and Helicobacter pylori.

In addition to BUGS’n BEADS™, DiaSorin nucleic acid extraction kits are available for: the extraction of RNA or DNA; the extraction of DNA from stool and blood samples; and cell separation.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Genetic Test Could Improve Blood Cancer Treatment
Testing for genetic risk factors could improve treatment for myeloma – a cancer of the blood and bone marrow – by helping doctors identify patients at risk of developing more aggressive disease.
PTR-MS Breath Test Shows Potential for Detecting Liver Disease
Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!